Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isolated dysphagia as initial sign of anti-IgLON5 syndrome.
Schröder JB, Melzer N, Ruck T, Heidbreder A, Kleffner I, Dittrich R, Muhle P, Warnecke T, Dziewas R. Schröder JB, et al. Among authors: melzer n. Neurol Neuroimmunol Neuroinflamm. 2016 Nov 22;4(1):e302. doi: 10.1212/NXI.0000000000000302. eCollection 2017 Jan. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27900347 Free PMC article.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
Gross CC, Ahmetspahic D, Ruck T, Schulte-Mecklenbeck A, Schwarte K, Jörgens S, Scheu S, Windhagen S, Graefe B, Melzer N, Klotz L, Arolt V, Wiendl H, Meuth SG, Alferink J. Gross CC, et al. Among authors: melzer n. Neurol Neuroimmunol Neuroinflamm. 2016 Oct 12;3(6):e289. doi: 10.1212/NXI.0000000000000289. eCollection 2016 Dec. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27766281 Free PMC article.
Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration.
Miske R, Gross CC, Scharf M, Golombeck KS, Hartwig M, Bhatia U, Schulte-Mecklenbeck A, Bönte K, Strippel C, Schöls L, Synofzik M, Lohmann H, Dettmann IM, Deppe M, Mindorf S, Warnecke T, Denno Y, Teegen B, Probst C, Brakopp S, Wandinger KP, Wiendl H, Stöcker W, Meuth SG, Komorowski L, Melzer N. Miske R, et al. Among authors: melzer n. Neurol Neuroimmunol Neuroinflamm. 2016 Dec 5;4(1):e307. doi: 10.1212/NXI.0000000000000307. eCollection 2017 Jan. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27957508 Free PMC article.
Understanding the burden of refractory myasthenia gravis.
Schneider-Gold C, Hagenacker T, Melzer N, Ruck T. Schneider-Gold C, et al. Among authors: melzer n. Ther Adv Neurol Disord. 2019 Mar 1;12:1756286419832242. doi: 10.1177/1756286419832242. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 30854027 Free PMC article. Review.
Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.
Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD. Keller CW, et al. Among authors: melzer n. Ann Clin Transl Neurol. 2019 Dec;6(12):2586-2594. doi: 10.1002/acn3.50935. Epub 2019 Nov 4. Ann Clin Transl Neurol. 2019. PMID: 31682087 Free PMC article.
177 results